Implications of respiratory motion for the quantification of 2D MR spectroscopic imaging data in the abdomen.

Magnetic resonance spectroscopic imaging (MRSI) studies in the abdomen or breast are acquired in the presence of respiratory motion. This modifies the point spread function (PSF) and hence the reconstructed spectra. We evaluated the quantitative effects of both periodic and aperiodic motion on spectra localized by MRSI. Artefactual signal changes, both the modification of native to a voxel and spurious signals arising elsewhere, depend primarily upon the motion amplitude relative to the voxel dimension. A similar dependence on motion amplitude was observed for simple harmonic motion (SHM), quasi-periodic motion and random displacements. No systematic dependence upon the period or initial phase of SHM or on the array size was found. There was also no significant variation with motion direction relative to the internal and external phase-encoding directions. In measured excursion ranges of 20 breast and abdominal tumours, 70% moved < or = 5 mm, while 30% moved 6-23 mm. The diaphragm and fatty tissues in the gut typically moved approximately 15-20 mm. While tumour/organ excursions less than half the voxel dimension do not substantially affect native signals, the bleeding in of strong lipid signals will be problematic in 1H studies. MRSI studies in the abdomen, even of relatively well-anchored tumours, are thus likely to benefit from the addition of respiratory triggering or other motion compensation strategies.

[1]  K M Brière,et al.  Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair , 1998, NMR in biomedicine.

[2]  J. Felmlee,et al.  Orbital navigator echoes for motion measurements in magnetic resonance imaging , 1995, Magnetic resonance in medicine.

[3]  A A Maudsley,et al.  In‐plane motion correction for MR spectroscopic imaging , 1998, Magnetic resonance in medicine.

[4]  J. Silverman,et al.  Navigated single‐voxel proton spectroscopy of the human liver , 1998, Magnetic resonance in medicine.

[5]  E. Haacke,et al.  Pseudo‐gating: Elimination of periodic motion artifacts in magnetic resonance imaging without gating , 1987, Magnetic resonance in medicine.

[6]  M. L. Wood,et al.  MR image artifacts from periodic motion. , 1985, Medical physics.

[7]  T R Brown,et al.  Practical applications of chemical shift imaging , 1992, NMR in biomedicine.

[8]  C J Hardy,et al.  Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants. , 1991, Radiology.

[9]  M. L. Wood,et al.  Planar‐motion correction with use of k‐space data acquired in fourier MR imaging , 1995, Journal of magnetic resonance imaging : JMRI.

[10]  P A Bottomley,et al.  Human cardiac high‐energy phosphate metabolite concentrations by 1D‐resolved NMR spectroscopy , 1996, Magnetic resonance in medicine.

[11]  S J Riederer,et al.  Compensation for effects of linear motion in MR imaging , 1989, Magnetic resonance in medicine.

[12]  R M Henkelman,et al.  K‐space description for MR imaging of dynamic objects , 1993, Magnetic resonance in medicine.

[13]  K. Stock,et al.  1H MRS of liver and brain in a patient with AL amyloidosis. , 1997, Magnetic resonance imaging.

[14]  J. Felmlee,et al.  Adaptive technique for high-definition MR imaging of moving structures. , 1989, Radiology.

[15]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[16]  T. Brown,et al.  Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. , 1995, Cancer research.

[17]  W. Perman,et al.  Spatially resolved high resolution spectroscopy by “four-dimensional” NMR , 1983 .

[18]  D. Collins,et al.  IN-VIVO 31P MAGNETIC RESONANCE SPECTROSCOPY FOR MONITORING TREATMENT RESPONSE IN BREAST CANCER , 1989, The Lancet.

[19]  J. Pauly,et al.  Feasibility study of lactate imaging of head and neck tumors , 1998, NMR in biomedicine.

[20]  K. Uğurbil,et al.  NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. G. Collins,et al.  Respiratory ordered phase encoding (ROPE): a method for reducing respiratory motion artefacts in MR imaging. , 1985, Journal of computer assisted tomography.

[22]  J Keegan,et al.  MR navigator‐echo monitoring of temporal changes in diaphragm position: Implications for MR coronary angiography , 1997, Journal of magnetic resonance imaging : JMRI.

[23]  H Yan,et al.  Motion artifact suppression: a review of post-processing techniques. , 1992, Magnetic resonance imaging.

[24]  J. Frahm,et al.  Localized proton MR spectroscopy of the human kidney in vivo by means of short echo time STEAM sequences , 1994, Magnetic resonance in medicine.

[25]  R. Alfidi,et al.  The effect of motion on two-dimensional Fourier transformation magnetic resonance images. , 1984, Radiology.

[26]  S. Neubauer,et al.  Clinical cardiac magnetic resonance spectroscopy— present state and future directions , 1998 .

[27]  D Atkinson,et al.  Automatic compensation of motion artifacts in MRI , 1999, Magnetic resonance in medicine.

[28]  David Atkinson,et al.  Automatic correction of motion artifacts in magnetic resonance images using an entropy focus criterion , 1997, IEEE Transactions on Medical Imaging.

[29]  G. Bydder,et al.  Some considerations concerning susceptibility, longitudinal relaxation time constants and motion artifacts in In vivo human spectroscopy , 1989, NMR in biomedicine.

[30]  R. Lenkinski,et al.  Human breast lesions: characterization with proton MR spectroscopy. , 1998, Radiology.

[31]  T. Brown,et al.  Molar Quantitation of Hepatic Metabolites In Vivo in Proton‐decoupled, Nuclear Overhauser Effect Enhanced 31P NMR Spectra Localized by Three‐dimensional Chemical Shift Imaging , 1996, NMR in biomedicine.

[32]  M. van der Graaf,et al.  In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. , 1997, Anticancer research.

[33]  T. Powles,et al.  Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment , 1998, NMR in biomedicine.

[34]  T. Brown,et al.  Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B1 inhomogeneity , 1998, Magnetic resonance in medicine.